As Regional Marketing Manager Whole Blood (m/f/d), you will shape the market development strategy for our Transfusion Medicine and Cell Therapies (TCT) line across the International & APAC region.
In this high-impact role, you act as the strategic driver of growth by aligning markets, integrating teams and digital connectivity solutions, and defining a strong regional vision for our blood collection categories.
Design and execute a comprehensive market development strategy for the Whole Blood Transfusion (WBT) line across the region
Oversee and optimize the WBT product portfolio, with a strong focus on differentiation through BPUs and connectivity solutions
Identify untapped markets (“white spots”) and lead therapy development initiatives
Develop and implement clear positioning, competitive differentiation, and regional go‑to‑market strategies
Analyze market trends and provide strategic recommendations through structured performance reporting
Coordinate regional priorities and ensure successful implementation with local adaptation
Bachelor’s degree in Marketing, Business Administration, Biomedical Engineering or a related field
At least 5 years of experience in marketing or product management within the medical device or healthcare industry, including 3+ years in a leadership role
Strong track record in managing regional market strategies, ideally in transfusion medicine or medical technology
Solid knowledge of regional and international healthcare/medical device industry regulations, standards, and trends
Proven ability to drive market share growth, develop competitive pricing, and manage product positioning across multiple markets
Strong financial acumen including budgeting, P&L management and ROI-driven decision-making
Excellent English skills (written and spoken); German or additional languages are an advantage
Drive the future of MedTech — become part of #futurefresenius and apply now via our online portal!
As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies.
In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is the global leader in supplying blood collection bags and devices, supporting blood banks and healthcare facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care.
Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. With the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare.
Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale.
User information & community guidelines: https://www.fresenius-kabi.com/social-media-terms-conditions
Imprint: www.fresenius-kabi.com/imprint
